Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension.

Volpe M, de la Sierra A, Ammentorp B, Laeis P.

Adv Ther. 2014 May;31(5):561-74. doi: 10.1007/s12325-014-0117-9. Epub 2014 Apr 24.

PMID:
24760656
[PubMed - in process]
2.

Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.

Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.

Clin Ther. 2010 Jul;32(7):1252-69. doi: 10.1016/j.clinthera.2010.07.008.

PMID:
20678674
[PubMed - indexed for MEDLINE]
3.

Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.

Fogari R, Taddei S, Holm-Bentzen M, Baszak J, Melani L, Schumacher K.

Clin Drug Investig. 2010;30(9):581-97. doi: 10.2165/11536710-000000000-00000. Erratum in: Clin Drug Investig. 2013 Jan;33(1):95.

PMID:
20593911
[PubMed - indexed for MEDLINE]
4.

Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.

Kereiakes DJ, Chrysant SG, Izzo JL Jr, Littlejohn T 3rd, Melino M, Lee J, Fernandez V, Heyrman R.

Cardiovasc Diabetol. 2012 Oct 30;11:134. doi: 10.1186/1475-2840-11-134.

PMID:
23110471
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.

Punzi HA.

Ther Adv Cardiovasc Dis. 2014 Feb;8(1):12-21. doi: 10.1177/1753944713520062.

PMID:
24492985
[PubMed - indexed for MEDLINE]
6.

Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.

Chrysant SG, Littlejohn T 3rd, Izzo JL Jr, Kereiakes DJ, Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.

Am J Cardiovasc Drugs. 2012 Aug 1;12(4):233-43. doi: 10.2165/11634160-000000000-00000.

PMID:
22799613
[PubMed - indexed for MEDLINE]
7.

Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.

Volpe M, Christian Rump L, Ammentorp B, Laeis P.

Clin Drug Investig. 2012 Oct 1;32(10):649-64. doi: 10.2165/11636320-000000000-00000.

PMID:
22909147
[PubMed - indexed for MEDLINE]
8.

Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.

Hsueh WA, Shojaee A, Maa JF, Neutel JM.

Curr Med Res Opin. 2012 Nov;28(11):1809-18. doi: 10.1185/03007995.2012.740632. Epub 2012 Oct 30.

PMID:
23072496
[PubMed - indexed for MEDLINE]
9.

Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.

Lewin AJ, Izzo JL Jr, Melino M, Lee J, Fernandez V, Heyrman R.

Drugs Aging. 2013 Jul;30(7):549-60. doi: 10.1007/s40266-013-0072-1.

PMID:
23549909
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Safety and tolerability of an olmesartan medoxomil-based regimen in patients with stage 1 hypertension: a randomized, double-blind, placebo-controlled study.

Chrysant SG.

Clin Drug Investig. 2010;30(7):473-82. doi: 10.2165/11536560-000000000-00000.

PMID:
20528002
[PubMed - indexed for MEDLINE]
11.

Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.

Volpe M, Miele C, Haag U.

Clin Drug Investig. 2009;29(6):381-91. doi: 10.2165/00044011-200929060-00002.

PMID:
19432498
[PubMed - indexed for MEDLINE]
12.

Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.

Volpe M, Brommer P, Haag U, Miele C.

Clin Drug Investig. 2009;29(1):11-25. doi: 10.2165/0044011-200929010-00002.

PMID:
19067471
[PubMed - indexed for MEDLINE]
13.

Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.

Lewin AJ, Kereiakes DJ, Chrysant SG, Izzo JL Jr, Oparil S, Lee J, Fernandez V, Melino M.

Ethn Dis. 2014 Winter;24(1):41-7.

PMID:
24620447
[PubMed - indexed for MEDLINE]
14.

Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.

Barrios V, Brommer P, Haag U, Calderón A, Escobar C.

Clin Drug Investig. 2009;29(7):427-39. doi: 10.2165/00044011-200929070-00001.

PMID:
19499960
[PubMed - indexed for MEDLINE]
15.
16.

Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.

Heagerty AM, Mallion JM.

Drugs Aging. 2009;26(1):61-76. doi: 10.2165/0002512-200926010-00005.

PMID:
19102515
[PubMed - indexed for MEDLINE]
17.

Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.

Germino FW, Neutel JM, Dubiel R, Maa JF, Chavanu KJ.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):325-33. doi: 10.2165/11635000-000000000-00000.

PMID:
22920048
[PubMed - indexed for MEDLINE]
18.

Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.

Neutel J, Shojaee A, Maa JF.

Adv Ther. 2012 Jun;29(6):508-23. doi: 10.1007/s12325-012-0030-z. Epub 2012 Jul 4.

PMID:
22773358
[PubMed - indexed for MEDLINE]
19.

Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study.

Neutel J, Kereiakes DJ, Stoakes KA, Maa JF, Shojaee A, Waverczak WF.

Drugs Aging. 2011 Jun 1;28(6):477-90. doi: 10.2165/11589460-000000000-00000.

PMID:
21639407
[PubMed - indexed for MEDLINE]
20.

Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension.

Kereiakes DJ, Chrysant SG, Izzo JL Jr, Littlejohn T 3rd, Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.

J Clin Hypertens (Greenwich). 2012 Mar;14(3):149-57. doi: 10.1111/j.1751-7176.2011.00588.x. Epub 2012 Jan 24.

PMID:
22372774
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk